2-Chloro-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol → HCID 178450286, compound
Reaction equation
Br[C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[CH:7][C:6]([C:12](=[O:16])[CH2:13][CH2:14][CH3:15])=[C:5]2[NH:17][C@H:18]1[CH2:23][CH2:22][C@H:21]([CH2:24][N:25]([CH3:27])[CH3:26])[CH2:20][CH2:19]1.[Cl:28][C:29]1[CH:34]=[C:33](B2OC(C)(C)C(C)(C)O2)[CH:32]=[C:31]([F:44])[C:30]=1[OH:45]>>[Cl:28][C:29]1[CH:34]=[C:33]([C:2]2[CH:3]=[C:4]3[C:9](=[CH:10][CH:11]=2)[N:8]=[CH:7][C:6]([C:12](=[O:16])[CH2:13][CH2:14][CH3:15])=[C:5]3[NH:17][C@H:18]2[CH2:19][CH2:20][C@H:21]([CH2:24][N:25]([CH3:27])[CH3:26])[CH2:22][CH2:23]2)[CH:32]=[C:31]([F:44])[C:30]=1[OH:45]Participants
3
Procedure
Following general procedure A-1, 1-{6-bromo-4-[trans-4-((dimethylamino)methyl)cyclohexylamino]quinolin-3-yl}butan-1-one (48 mg, 0.110 mmol) was reacted with 2-chloro-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (45 mg, 0.165 mmol) to afford the desired product (36 mg, 67%) as a yellow solid: 1H NMR (500 MHz, CD3OD+TFA-d) δ 9.14 (s, 1H), 8.47 (s, 1H), 8.26 (dd, J=8.7, 1.8 Hz, 1H), 7.98 (d, J=8.7 Hz, 1H), 7.58 (s, 1H), 7.50 (d, J=11.3 Hz, 1H), 4.52 (s, 1H), 3.16-3.05 (m, 4H), 2.95 (s, 6H), 2.49-2.43 (m, 2H), 2.08-2.01 (m, 2H), 1.85-1.74 (m, 4H), 1.41-1.32 (m, 1H), 1.09-1.02 (t, J=7.4 Hz, 3H); ESI MS m/z 498 [C28H33ClFN3O2+H]+; HPLC>99% (AUC), tR=11.08 min.
Sources & evidence
- ORD record
- ord-aeac9d056a394259a75505d6d3ba583e
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09120749B2
Reaction notes
Loading…